Trial Profile
Efficacy and Tolerability of Ramelteon for treatment of Insomnia - An open-label, randomized, comparative study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Ranbaxy Laboratories
- 30 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 13 Feb 2010 New trial record